Skip to main content

Search UC San Diego Today

Keyword is required

Your search for “Oncology” returned 285 results

Active Surveillance Safe for African Americans with Low-Risk Prostate Cancer

Researchers with UC San Diego School of Medicine and Moores Cancer Center say active surveillance is safe for African American men with low-risk prostate cancer.

Chatter Between Cell Populations Drives Progression of Gastrointestinal Tumors

Researchers at University of California San Diego School of Medicine identified new therapeutic targets for gastrointestinal stromal tumors (GISTs) that could lead to new treatment options for patients.

Genetic Tool Improves Estimation of Prostate Cancer Risk in Diverse Ethnic/Racial Groups

Scientists at University of California San Diego School of Medicine validated a more inclusive and comprehensive genetic tool, known as a polygenic hazard score (PHS), for predicting age of onset of aggressive prostate cancer.

Genetic Changes in Head and Neck Cancer, Immunotherapy Resistance Identified

A multi-institutional team of researchers, led by UC San Diego School of Medicine and Moores Cancer Center, has identified both the genetic abnormalities that drive pre-cancer cells into becoming an invasive type of head and neck cancer and patients who are least likely to respond to immunotherapy.

UC San Diego Health Begins Treating Multiple Myeloma with CAR T-cell Therapy

As the first designated medical center in San Diego certified to offer this type of immunotherapy, UC San Diego Health will begin treating patients this month.

At Initial Cancer Diagnosis, a Deeply Personalized Assessment

UC San Diego researchers report that conducting genomic evaluations of advanced malignancies can be effective in guiding first-line-of-treatment, rather than waiting until standard-of-care therapies have failed.

Transplant, Cancer Patients Among First to Get Evusheld at UC San Diego Health

UC San Diego Health is now administering Evusheld to eligible, immunocompromised patients to protect against the COVID-19 virus.

New Radiation Therapy Delays Brain Cancer Regrowth, Protects Healthy Tissue

UC San Diego Health now offers a novel therapy option shown to extend the lifespan and improve quality of life for certain patients.

New Treatment for Urinary Tract Cancer Could Prevent Kidney Dialysis, Transplant

UC San Diego Health is now offering a new treatment for patients with low-grade upper tract urothelial cancer that could safely avoid removal of the entire kidney, which may prevent the need for dialysis or kidney transplant in the future.

Gene Therapy Finds New Life in an Old Home

An international symposium November 17-18, 2022 at UC San Diego will discuss current clinical trials using gene therapy, here and abroad.